MDNA.TOMDNA.TOTSX
Loading
Year-over-year research & development expense growth
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -0.83% |
| Q3 2025 | -2.38% |
| Q2 2025 | -6.39% |
| Q1 2025 | 30.56% |
| Q4 2024 | -7.62% |
| Q3 2024 | 33.93% |
| Q2 2024 | 49.33% |
| Q1 2024 | -37.71% |
| Q4 2023 | -4.56% |
| Q3 2023 | 11.45% |
| Q2 2023 | 77.30% |
| Q1 2023 | -46.15% |
| Q4 2022 | 24.68% |
| Q3 2022 | -2.03% |
| Q2 2022 | 102.43% |
| Q1 2022 | -59.03% |
| Q4 2021 | -53.63% |
| Q3 2021 | 44.15% |
| Q2 2021 | 17.51% |
| Q1 2021 | 16.38% |
| Q4 2020 | 46.14% |
| Q3 2020 | 20.02% |
| Q2 2020 | -15.09% |
| Q1 2020 | 28.68% |
| Q4 2019 | 33.15% |
| Q3 2019 | 50.44% |
| Q2 2019 | 25.27% |
| Q1 2019 | -48.17% |
| Q4 2018 | 186.19% |
| Q3 2018 | -29.79% |
| Q2 2018 | -26.51% |
| Q1 2018 | -36.08% |
| Q4 2017 | 26.37% |
| Q3 2017 | -40.73% |
| Q2 2017 | -11.73% |
| Q1 2017 | 27.95% |
| Q4 2016 | 44.45% |
| Q3 2016 | 11.02% |
| Q2 2016 | -7.96% |
| Q1 2016 | 75.08% |